@article{6e696ead16e0461082d6170fa418cd8c,
title = "Collaboration for the Management of Hydroxychloroquine",
author = "Rosenbaum, {James T.} and Costenbader, {Karen H.} and Julianna Desmarais and Ginzler, {Ellen M.} and Nicole Fett and Goodman, {Susan M.} and O'Dell, {James R.} and Gabriela Schmajuk and Werth, {Victoria P.} and Melles, {Ronald B.} and Marmor, {Michael F.}",
note = "Funding Information: The author(s) have made the following disclosure(s): J.T.R.: Consultant – AbbVie, UCB, Gilead, Novartis, Horizon, Roche, Eyevensys, Santen, Corvus, Affibody, Kyverna; Financial support – Pfizer, Horizon; Royalties – UpToDate K.H.C.: Consultant – Neutrolis, Merck; Financial support – Merck, Janssen, Astra Zeneca, GSK; Equity owner – Alkermes, Generex; Royalties – UpToDate E.M.G.: Consultant – AbbVie; Financial support – Aurina, Lilly, GSK N.F.: Financial support – Lilly and Pfizer; Royalties – UpToDate S.M.G.: Consultant – UCB, Pfizer; Financial support – Horizon Pharma, Novartis, Pfizer V.P.W.: Consultant – Celgene, Medimmune, Resolve, Genentech, Idera, Janssen, Lilly, Pfizer, Biogen, BMS, Gilead, Amgen, Medscape, Nektar, Incyte, EMD Serona, CSL Behring, Principia, Crisalis, Viela Bio, Argenx, Kirin, Regeneron, Principia, AstraZeneca, Abbvie, Octapharma, GSK, Astra-Zeneca; Financial support – Celgene, Janssen, Pfizer, Biogen, Gilead, Corvus Pharmaceuticals, Genentech, AstraZeneca, Viela, Syntimmune; University of Pennsylvania owns the copyright for the CLASI and CDASI",
year = "2021",
month = jul,
doi = "10.1016/j.ophtha.2021.02.015",
language = "English (US)",
volume = "128",
pages = "1115--1116",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "7",
}